SPEECH THERAPY CLINIC BUSINESS PLAN

I. Executive Summary

Company Description

The company name is not provided. We operate in the healthcare sector, specifically outpatient speech-language pathology, delivering diagnostic assessments and individualized therapy for children and adults. Our team consists of state-licensed and ASHA-certified Speech-Language Pathologists who provide one-on-one treatment in a state-of-the-art clinic. We focus on clinical excellence, family collaboration, and measurable progress. Target patients include pediatric and adult clients with communication disorders, developmental speech delays, voice disorders, aphasia, and related conditions. One-line summary: high-quality, family-centered speech therapy delivered by licensed experts.

Short-term goals are to open the clinic in 2026, achieve operational readiness, onboard full clinical staff, and establish referral pathways with local pediatricians, schools, and neurologists. Long-term goals are to maintain measurable clinical outcomes, expand capacity, add teletherapy options, and build a regional reputation for excellence. Key differentiators are licensed ASHA-certified clinicians, a dedicated assessment suite, and structured family-engagement protocols. One-line summary: start strong in 2026, scale responsibly while protecting clinical quality.

Problem

Millions of Americans have communication disorders that create real barriers to learning, work, and social life. There is a critical shortage of specialized facilities offering integrated, family-centered care. Families struggle to find state-licensed, ASHA-certified speech-language pathology services that combine diagnostic assessment with coordinated therapy across speech, language, and cognitive domains.

Those gaps limit access to evidence-based therapy, raise caregiver burden and out-of-pocket costs, delay recovery after neurological injury, and increase school and workplace underperformance and social isolation.

One line: A clear shortage of coordinated, evidence-based speech and communication care prevents millions from reaching their full academic, social, and professional potential.

Solution

Compassionate, evidence-based speech and language therapy delivered by state-licensed, ASHA-certified speech-language pathologists closes a clear market gap: millions of Americans with communication disorders lack holistic, family-centered care and specialized tools. Our clinic provides personalized treatment plans for articulation, fluency, voice, and language comprehension, backed by state-of-the-art diagnostics and a supportive environment tailored to each client and family.

One line: We restore confident communication with personalized, evidence-based therapy and family-centered support.

Mission Statement

We empower children and adults to find their voice and connect confidently with the world through expert, compassionate, evidence-based speech and language therapy. We provide family-centered care that pairs clinical best practices with measurable goals and caregiver coaching to drive lasting communication gains. We commit to equitable access, continuous outcome tracking, and community partnerships that expand reach and improve quality.

Key Success Factors

Critical capabilities and assets that will drive clinic performance and patient outcomes.

• ASHA-certified multidisciplinary therapists delivering specialized care across speech, language, and feeding.
• High utilization (85–90% by 2030) enabling efficient clinician capacity and revenue per clinician.
• Established referral network with pediatricians, neurologists, and local schools supplying steady patient flow.
• State-of-the-art facility and diagnostics that differentiate services and support accurate treatment plans.
• Family-centered care with caregiver training driving superior outcomes and high satisfaction.

Financial Summary

Key financials for the speech therapy clinic launching in 2026, showing revenue growth, path to breakeven, and investor returns.

The business requires an initial capital investment of $203,000; breakeven is forecast for January 2029 with a payback period of 58 months. The modeled five-year return metrics are ROE 58% and IRR 0.01%.

Overall outlook: accelerating revenue and EBITDA turning positive by Year 4, supporting a reasonable equity return over five years.

Funding Requirements

The clinic requires an initial capital injection of $203,000 and a total of approximately $850,000 to reach breakeven in January 2029.